Physical Therapy in Wound Care A Cost-Effectiveness Analysis

被引:16
|
作者
Zhou, Kehua [1 ,2 ]
Krug, Kenneth [1 ]
Brogan, Michael S. [3 ]
机构
[1] Daemen Coll, Daemen Coll Phys Therapy Wound Care Clin, Amherst, NY USA
[2] Daemen Coll, Dept Hlth Care Studies, Amherst, NY USA
[3] Daemen Coll, Dept Phys Therapy, Amherst, NY USA
关键词
ELECTRICAL-STIMULATION; CHRONIC ULCER; FOOT; LEG;
D O I
10.1097/MD.0000000000002202
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Management of chronic wounds remains unsatisfactory in terms of treatment cost and time required for complete wound closure (CWC).This study aimed to calculate the healing rates, estimated cost, and time required for CWC in wounds; compare estimated wound care costs between healing and nonhealing wounds; and compare cost effectiveness between venous leg ulcer (VLU) and non-VLU.This was a retrospective cohort study performed at a physical therapy (PT) wound care clinic. Deidentified patient data in the electronic medical database from September 10, 2012 to January 23, 2015 were extracted.Among 159 included patients with wounds, 119 (74.84%) patients were healed with CWC. The included patients were treated for 109.7095.70 days, 29.7125.66 visits, and at the costs per treatment episode of $1629.65 +/- 1378.82 per reimbursement rate and $2711.42 +/- 2356.81 per breakeven rate. For patients with CWC (healing group), the treatment duration was 98.01 +/- 76.12 days with the time for CWC as 72.45 +/- 64.21 days; the cost per treatment episode was $1327.24 +/- 1143.53 for reimbursement rate and $2492.58 +/- 2106.88 for breakeven cost. For patients with nonhealing wounds, treatment duration was found to be longer with costs significantly higher (P<0.01 for all). In the healing group, no differences were found between VLU and non-VLU in treatment duration (95.46 days vs. 100.88 days, P=0.698), time for CWC (68.06 days vs. 77.38 days, P=0.431), and cost ($2756.78 vs. 2397.84 for breakeven rate, P=0.640) with the exception of wound dressing costs ($329.19 vs. 146.47, P=0.001).Healing rates may be affected with patient exclusions. Costs at physicians' offices were not included.Incorporation of PT in wound care appeared to be cost effective. PT may thus be a good referral option for patients with wounds. However, the results should be interpreted cautiously and further studies are warranted.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] Cost-effectiveness Research in Wound Care: Definitions, Approaches, and Limitations
    Carter, Marissa J.
    OSTOMY WOUND MANAGEMENT, 2010, 56 (11) : 48 - 59
  • [12] Cost-effectiveness analysis alongside a pilot study of prophylactic negative pressure wound therapy
    Heard, Christopher
    Chaboyer, Wendy
    Anderson, Vinah
    Gillespie, Brigid M.
    Whitty, Jennifer A.
    JOURNAL OF TISSUE VIABILITY, 2017, 26 (01) : 79 - 84
  • [13] COST-EFFECTIVENESS OF HOME HEALTH-CARE FOR BURN PATIENTS - A PHYSICAL THERAPY PERSPECTIVE
    SHAW, S
    POTTS, L
    PHYSICAL THERAPY, 1988, 68 (05): : 856 - 857
  • [14] TAI CHI VERSUS PHYSICAL THERAPY FOR KNEE OSTEOARTHRITIS: A COST-EFFECTIVENESS ANALYSIS
    Wong, J. B.
    Chung, M.
    Price, L.
    Wang, C.
    OSTEOARTHRITIS AND CARTILAGE, 2018, 26 : S312 - S313
  • [15] COST-EFFECTIVENESS ANALYSIS IN HEALTH-CARE
    EMERY, DD
    SCHNEIDERMAN, LJ
    HASTINGS CENTER REPORT, 1989, 19 (04) : 8 - 13
  • [16] Antibiotic therapy of nosocomial infection in the intensive care unit: A cost-effectiveness analysis
    Kulikov, A.
    Krysanov, I
    Lomakin, A.
    VALUE IN HEALTH, 2006, 9 (06) : A299 - A299
  • [17] MODELING ZIDOVUDINE THERAPY - A COST-EFFECTIVENESS ANALYSIS
    PALTIEL, AD
    KAPLAN, EH
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1991, 4 (08): : 795 - 804
  • [18] Therapy of hepatitis C: Cost-effectiveness analysis
    Koff, RS
    HEPATOLOGY, 1997, 26 (03) : S152 - S155
  • [19] Gene therapy in hemophilia A: a cost-effectiveness analysis
    Machin, Nicoletta
    Ragni, Margaret V.
    Smith, Kenneth J.
    BLOOD ADVANCES, 2018, 2 (14) : 1792 - 1798
  • [20] Cost-Effectiveness Analysis of individualized Diabetes Therapy
    Pavlicek, V.
    DIABETOLOGE, 2018, 14 (03): : 180 - 181